UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 86 filers reported holding UTAH MED PRODS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $803,068 | -7.7% | 9,338 | 0.0% | 0.09% | -3.1% |
| Q2 2023 | $870,302 | -5.4% | 9,338 | -3.8% | 0.10% | -13.4% |
| Q1 2023 | $920,217 | -5.7% | 9,710 | 0.0% | 0.11% | -9.7% |
| Q4 2022 | $976,146 | +17.9% | 9,710 | 0.0% | 0.12% | -12.7% |
| Q3 2022 | $828,000 | -0.7% | 9,710 | 0.0% | 0.14% | -30.0% |
| Q2 2022 | $834,000 | -4.5% | 9,710 | 0.0% | 0.20% | +14.7% |
| Q1 2022 | $873,000 | -55.0% | 9,710 | -50.0% | 0.18% | -11.1% |
| Q4 2021 | $1,942,000 | +230.3% | 19,420 | +206.5% | 0.20% | +55.5% |
| Q3 2021 | $588,000 | +9.1% | 6,336 | 0.0% | 0.13% | +32.0% |
| Q2 2021 | $539,000 | -1.8% | 6,336 | 0.0% | 0.10% | -3.0% |
| Q1 2021 | $549,000 | +2.8% | 6,336 | 0.0% | 0.10% | -12.3% |
| Q4 2020 | $534,000 | +5.5% | 6,336 | 0.0% | 0.11% | -14.9% |
| Q3 2020 | $506,000 | +1.8% | 6,336 | +13.0% | 0.13% | +6.3% |
| Q2 2020 | $497,000 | – | 5,605 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clean Yield Group | 49,094 | $3,535,000 | 1.48% |
| MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 27,464 | $1,988,000 | 0.72% |
| Ativo Capital Management LLC | 16,525 | $1,196,000 | 0.33% |
| Ancora Advisors LLC | 55,159 | $3,993,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 10,754 | $779,000 | 0.23% |
| Cardinal Capital Management | 9,180 | $665,000 | 0.22% |
| Acrospire Investment Management LLC | 1,919 | $139,000 | 0.13% |
| Penobscot Investment Management Company, Inc. | 4,000 | $290,000 | 0.09% |
| TFS CAPITAL LLC | 3,226 | $234,000 | 0.09% |
| WCM INVESTMENT MANAGEMENT, LLC | 81,912 | $5,930,000 | 0.09% |